跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

B5016

Sigma-Aldrich

苄普地尔 盐酸盐

powder

别名:

1-异丁氧基-2-吡咯烷基-3-（N-苄基苯胺）丙烷 盐酸盐

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C24H34N2O · HCl
CAS号:
68099-86-5
分子量:
403.00
MDL號碼:
MFCD00065498
分類程式碼代碼:
12352202
PubChem物質ID:
24277824
NACRES:
NA.77

形狀

powder

起源

Johnson & Johnson

SMILES 字串

Cl.CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3

InChI

1S/C24H34N2O.ClH/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22;/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3;1H

InChI 密鑰

JXBBWYGMTNAYNM-UHFFFAOYSA-N

基因資訊

human ... CACNA1A(773) , CACNA1B(774) , CACNA1C(775) , CACNA1D(776) , CACNA1E(777) , CACNA1F(778) , CACNA1G(8913) , CACNA1H(8912) , CACNA1I(8911) , CACNA1S(779) , CACNA2D1(781) , CACNA2D2(9254) , CACNA2D3(55799) , CACNA2D4(93589) , CACNB1(782) , CACNB2(783) , CACNB3(784) , CACNB4(785) , CACNG1(786) , CACNG2(10369) , CACNG3(10368) , CACNG4(27092) , CACNG5(27091) , CACNG6(59285) , CACNG7(59284) , CACNG8(59283)

生化／生理作用

非选择性钙通道阻滞剂和 IV 类抗心律失常药；抑制Na+-Ca2+ 交换；体外抑制脑肿瘤细胞的生长。

特點和優勢

该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表，请点击此处。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 2

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCF3417
BCCB4077
BCBW5153
BCBT1451
BCBQ7735V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Chikako Shimizu et al.
Biological & pharmaceutical bulletin, 41(7), 1049-1061 (2018-05-18)
Ethanol (EtOH) dosage, frequency, and paired associative learning affect the risk of alcoholism. Recently, Spanagel et al. reported that acamprosate calcium (Acam Ca) prescribed for alcoholism exerts an anti-relapse effect via Ca. Ca is contained in foods, sometimes consumed with
Juliana Q Reimão et al.
Experimental parasitology, 128(2), 111-115 (2011-03-01)
The need for novel and efficacious drugs against neglected parasitic diseases, such as Leishmaniasis and American Trypanosomiasis, is certainly apparent. In this work, we evaluated the in vitro potential of the calcium channel blocker bepridil against Leishmania spp. and Trypanosoma
Xin Cao et al.
Journal of pharmacological sciences, 141(4), 153-159 (2019-11-24)
Experimental evidence regarding the risk of proarrhythmic potential of acehytisine is limited. We assessed its electropharmacological effect together with proarrhythmic potential at intravenous doses of 4 and 10 mg/kg (n = 6) using isoflurane-anesthetized guinea pigs in comparison with that of bepridil at
Tsuyoshi Shiga et al.
Circulation journal : official journal of the Japanese Circulation Society, 75(6), 1334-1342 (2011-04-13)
It is unknown whether bepridil improves cardiovascular events in atrial fibrillation (AF) patients, so this study evaluated the clinical outcome in paroxysmal or persistent AF patients receiving bepridil. We conducted a cohort study of 284 consecutive patients who received bepridil
Y Li et al.
The Journal of pharmacology and experimental therapeutics, 291(2), 562-568 (1999-10-19)
The effects of bepridil, a potent antiarrhythmic drug, on the activity of ATP-sensitive K(+) (K(ATP)) channels and Na(+)-activated K(+) (K(Na)) channels were examined in isolated patches from guinea pig ventricular myocytes. In inside-out membrane patches, K(ATP) channel currents were recorded
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门